Cai Xiaomin, Chen Zheng, Chang Bowen, Tu Ming, Li Shiting, Wang Xuhui, Chen Ming
Department of Neurosurgery, Xinhua Hospital of Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Front Oncol. 2022 Aug 8;12:937345. doi: 10.3389/fonc.2022.937345. eCollection 2022.
Ring enhancement on magnetic resonance imaging (MRI) is an important characteristic of GBM. Though patients suffering from glioblastoma multiforme (GBM) with BRAF mutation (MUT BRAF) in V600E benefit from BRAF-targeted inhibitors, the relationship between ring enhancement and MUT BRAF remains elusive. The purpose of this study was to investigate the relationship between BRAF mutation status and the appearance of ring enhancement so as to guide preoperative targeted therapy for MUT BRAF GBM.
Patient's population, clinical data and characteristic ring enhancement appearances on MRI were compared between GBM with MUT BRAF and GBM with WT BRAF. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the differential diagnostic significance. A nomogram was developed to predict the mutation status of BRAF. Moreover, all the variables were re-analyzed between epithelioid GBM (E-GBM) with or without MUT BRAF.
Compared to GBM with WT BRAF, GBM with MUT BRAF had specific ring enhancement appearances with multiple rings, multiple located lobes, regular shape of ring, uniform thickness of ring and smaller diameter of ring. Area under the curve (AUC) of all the variables' combination was 0.929. The nomogram was developed and validated. The re-analyzed results between E-GBM with or without MUT BRAF were similar to these above. AUC of the combination of quantity of ring, quantity of located lobe and shape of ring was 0.962.
The characteristic ring enhancement appearances of GBM may play an important role in predicting BRAF mutation status preoperatively, especially in E-GBM. Further study with larger cases may provide more evidences to guide the pretreatment of targeted medicine for GBM patients with MUT BRAF in future.
磁共振成像(MRI)上的环形强化是胶质母细胞瘤(GBM)的一个重要特征。虽然携带V600E BRAF突变(MUT BRAF)的多形性胶质母细胞瘤(GBM)患者可从BRAF靶向抑制剂中获益,但环形强化与MUT BRAF之间的关系仍不明确。本研究的目的是探讨BRAF突变状态与环形强化表现之间的关系,以指导MUT BRAF GBM的术前靶向治疗。
比较了MUT BRAF的GBM和野生型BRAF(WT BRAF)的GBM患者的人群、临床数据以及MRI上特征性的环形强化表现。进行了受试者操作特征(ROC)曲线分析以评估鉴别诊断意义。绘制了列线图以预测BRAF的突变状态。此外,对有或无MUT BRAF的上皮样GBM(E-GBM)之间的所有变量进行了重新分析。
与WT BRAF的GBM相比,MUT BRAF的GBM具有特定的环形强化表现,包括多个环、多个定位叶、环的形状规则、环的厚度均匀以及环的直径较小。所有变量组合的曲线下面积(AUC)为0.929。绘制并验证了列线图。有或无MUT BRAF的E-GBM之间的重新分析结果与上述结果相似。环数量、定位叶数量和环形状组合的AUC为0.962。
GBM的特征性环形强化表现可能在术前预测BRAF突变状态中起重要作用,尤其是在E-GBM中。未来更大样本量的进一步研究可能会提供更多证据,以指导MUT BRAF的GBM患者的靶向药物预处理。